Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 27-32

  Zhu, Meifen ^a   Wang, Ning ^a   Tsao, Sai Wah ^b   Yuen, Man Fung ^b   Feng, Yigang ^c   Wan, Thomas S K ^b   Man, Kwan ^b   Feng, Yibin ^a  

^a School of Chinese Medicine

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Coptidis rhizoma aqueous extract; Hepatocellular carcinoma; MicroRNA; miR 21; miR 23a

Indexed keywords

COPTIS RHIZOME EXTRACT; MICRORNA; MICRORNA 21; MICRORNA 23 A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CYTOTOXICITY; GENE TARGETING; HUMAN; HUMAN CELL; LIVER CANCER; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 78751622851     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.164     Document Type: Article

References (32)

1. Cahill BAand Braccia D: Current treatment for hepatocellular carcinoma. Clin J Oncol Nurs 8: 393-399, 2004.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics. CACancer J Clin 55: 74-108, 2005.
3. Lee RC, Feinbaum RLand Ambros V: The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
4. Ruvkun G: Molecular biology: glimpses of a tiny RNAworld. Science 294: 797-799, 2001.
5. Ji J, Shi J, Budhu A, et al: MicroRNAexpression, survival, and response to interferon in liver cancer. NEngl J Med 361: 1437-1447, 2009.
6. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ and Hammond SM: AmicroRNApolycistron as a potential human oncogene. Nature 435: 828-833, 2005.
7. Chang HM and Paul But PH: Pharmacology and Applications of Chinese Materia Medica. World Scientific Publishing, Singapore, pp1061-1077, 2001.
8. Kim HY, Shin HS, Park H, Kim YC, Yun YG, Park S, Shin HJ and Kim K: In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma and Phellodendron cortex. J Clin Virol 41: 122-128, 2008.
9. Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau GK, Sze C, Zhang Y, Tang J, Shen J and Kobayashi S: Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol 124: 130-136, 2009.
10. Tang J, Feng Y, Tsao S, Wang N, Curtain Rand Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17, 2009.
11. Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, Tsao SW and Feng Y: Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 24: 131-138, 2009.
12. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
13. Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C, Huang K and Fei J: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci 101: 948-954, 2010.
14. Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF and Wang ED: MicroRNA-155 functions as an oncomiRin breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127, 2010.
15. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and Guo L: miR-126 inhibits non-small cell lung cancer cell proliferation by targeting EGFL7. Biochem Biophys Res Commun 391: 1483-1489, 2010.
16. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GAand Mukherjee P: MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090-9095, 2009.
17. Bhattacharyya SN, Habermacher R, Martine U, Closs EIand Filipowicz W: Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124, 2006.
18. Feng Y, Cheung KF, Wang N, Liu P, Nagamatsu Tand Tong Y: Chinese medicines as a resource for liver fibrosis treatment. Chin Med 4: 16, 2009.
19. Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol 100: 72-79, 2005.
20. Yang LQ, Singh M, Yap EH, Ng GC, Xu HXand Sim KY: In vitro response of Blastocystis hominis against traditional Chinese medicine. J Ethnopharmacol 55: 35-42, 1996.
21. Feng Y, Luo WQ and Zhu SQ: Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use. Zhongguo Zhong Yao Za Zhi 33: 1221-1225, 2008.
22. Luo WQ, Hui SC, Chan TY and Feng Y: Inhibitory effect of water extract from golden thread (Huanglian) on leukemia L-1210 cells cultured in vitro. Pharmacologist 44: 126, 2002.
23. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, van Eyk JE, Mendell JTand Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458: 762-765, 2009.
24. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YXand Shao JY: MicroRNAmiR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360, 2008.
25. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DHand Kurzrock R: Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-473, 2008.
26. Li Y and Sarkar FH: Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 186: 157-164, 2002.
27. Garikapaty VP, Ashok BT, Tadi K, Mittelman Aand Tiwari RK: 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340: 718-725, 2006.
28. Katiyar SK, Afaq F, Perez Aand Mukhtar H: Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22: 287-294, 2001.
29. Kundu JK and Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269: 243-261, 2008.
30. Zhu S, Si ML, Wu Hand Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007.
31. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh Aand Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNAmiR-21 in breast cancer cells. J Biol Chem 283: 1026-1033, 2008.
32. Papagiannakopoulos T, Shapiro Aand Kosik KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172, 2008.